Published 23:08 IST, October 22nd 2020
Covaxin, Bharat Biotech's COVID vaccine, gets DCGI approval for phase 3 of clinical trials
India's indigenous developed COVID-19 vaccine - Covaxin - has been cleared by the Drug Controller General of India (DGCI) for the third phase of clinical trials
null | Image:
self
Advertisement
Loading...
21:52 IST, October 22nd 2020